Department of General Surgery, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China.
World J Gastroenterol. 2013 Aug 21;19(31):5150-8. doi: 10.3748/wjg.v19.i31.5150.
To investigate the lymph node metastasis patterns of gallbladder cancer (GBC) and evaluate the optimal categorization of nodal status as a critical prognostic factor.
From May 1995 to December 2010, a total of 78 consecutive patients with GBC underwent a radical resection at Liaocheng People's Hospital. A radical resection was defined as removing both the primary tumor and the regional lymph nodes of the gallbladder. Demographic, operative and pathologic data were recorded. The lymph nodes retrieved were examined histologically for metastases routinely from each node. The positive lymph node count (PLNC) as well as the total lymph node count (TLNC) was recorded for each patient. Then the metastatic to examined lymph nodes ratio (LNR) was calculated. Disease-specific survival (DSS) and predictors of outcome were analyzed.
With a median follow-up time of 26.50 mo (range, 2-132 mo), median DSS was 29.00 ± 3.92 mo (5-year survival rate, 20.51%). Nodal disease was found in 37 patients (47.44%). DSS of node-negative patients was significantly better than that of node-positive patients (median DSS, 40 mo vs 17 mo, χ² = 14.814, P < 0.001), while there was no significant difference between N1 patients and N2 patients (median DSS, 18 mo vs 13 mo, χ² = 0.741, P = 0.389). Optimal TLNC was determined to be four. When node-negative patients were divided according to TLNC, there was no difference in DSS between TLNC < 4 subgroup and TLNC ≥ 4 subgroup (median DSS, 37 mo vs 54 mo, χ² = 0.715, P = 0.398). For node-positive patients, DSS of TLNC < 4 subgroup was worse than that of TLNC ≥ 4 subgroup (median DSS, 13 mo vs 21 mo, χ² = 11.035, P < 0.001). Moreover, for node-positive patients, a new cut-off value of six nodes was identified for the number of TLNC that clearly stratified them into 2 separate survival groups (< 6 or ≥ 6, respectively; median DSS, 15 mo vs 33 mo, χ² = 11.820, P < 0.001). DSS progressively worsened with increasing PLNC and LNR, but no definite cut-off value could be identified. Multivariate analysis revealed histological grade, tumor node metastasis staging, TNLC and LNR to be independent predictors of DSS. Neither location of positive lymph nodes nor PNLC were identified as an independent variable by multivariate analysis.
Both TLNC and LNR are strong predictors of outcome after curative resection for GBC. The retrieval and examination of at least 6 nodes can influence staging quality and DSS, especially in node-positive patients.
研究胆囊癌(GBC)的淋巴结转移模式,并评估淋巴结状态的最佳分类作为关键预后因素。
1995 年 5 月至 2010 年 12 月,共有 78 例 GBC 患者在聊城市人民医院接受根治性切除术。根治性切除术定义为同时切除原发肿瘤和胆囊的区域淋巴结。记录人口统计学、手术和病理数据。从每个淋巴结常规检查转移的组织学特征。记录每个患者的阳性淋巴结计数(PLNC)和总淋巴结计数(TLNC)。然后计算转移至检查淋巴结的比例(LNR)。分析疾病特异性生存(DSS)和预后预测因素。
中位随访时间为 26.50 个月(范围,2-132 个月),中位 DSS 为 29.00±3.92 个月(5 年生存率为 20.51%)。37 例患者(47.44%)发现淋巴结疾病。阴性淋巴结患者的 DSS 明显优于阳性淋巴结患者(中位 DSS,40 个月比 17 个月,χ²=14.814,P<0.001),而 N1 患者与 N2 患者之间无显著差异(中位 DSS,18 个月比 13 个月,χ²=0.741,P=0.389)。确定最佳 TLNC 为 4。当根据 TLNC 将阴性淋巴结患者分为两组时,TLNC<4 亚组与 TLNC≥4 亚组之间的 DSS 无差异(中位 DSS,37 个月比 54 个月,χ²=0.715,P=0.398)。对于阳性淋巴结患者,TLNC<4 亚组的 DSS 比 TLNC≥4 亚组差(中位 DSS,13 个月比 21 个月,χ²=11.035,P<0.001)。此外,对于阳性淋巴结患者,确定了新的 TLNC 截断值为 6 个,可将其明确分为 2 个单独的生存组(<6 个或≥6 个,分别为;中位 DSS,15 个月比 33 个月,χ²=11.820,P<0.001)。随着 PLNC 和 LNR 的增加,DSS 逐渐恶化,但无法确定明确的截断值。多变量分析显示组织学分级、肿瘤淋巴结转移分期、TNLC 和 LNR 是 DSS 的独立预测因素。多变量分析未确定阳性淋巴结的位置或 PLNC 为独立变量。
TLNC 和 LNR 都是 GBC 根治性切除后预后的强有力预测指标。至少 6 个淋巴结的检索和检查可影响分期质量和 DSS,尤其是在阳性淋巴结患者中。